nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.104	0.157	CbGbCtD
Vinorelbine—ABCB1—Betamethasone—ankylosing spondylitis	0.0673	0.102	CbGbCtD
Vinorelbine—ABCB1—Prednisolone—ankylosing spondylitis	0.0664	0.101	CbGbCtD
Vinorelbine—ABCB1—Prednisone—ankylosing spondylitis	0.0627	0.0954	CbGbCtD
Vinorelbine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.062	0.0943	CbGbCtD
Vinorelbine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.047	0.0715	CbGbCtD
Vinorelbine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0403	0.0613	CbGbCtD
Vinorelbine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0398	0.0605	CbGbCtD
Vinorelbine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0392	0.0595	CbGbCtD
Vinorelbine—CYP3A4—Prednisone—ankylosing spondylitis	0.0376	0.0571	CbGbCtD
Vinorelbine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0369	0.0561	CbGbCtD
Vinorelbine—ABCB1—Methotrexate—ankylosing spondylitis	0.0315	0.0478	CbGbCtD
Vinorelbine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0235	0.0357	CbGbCtD
Vinorelbine—TUBB2B—Orphan transporters—ANO6—ankylosing spondylitis	0.0015	0.0846	CbGpPWpGaD
Vinorelbine—TUBB6—Orphan transporters—ANO6—ankylosing spondylitis	0.0015	0.0846	CbGpPWpGaD
Vinorelbine—TUBB3—Orphan transporters—ANO6—ankylosing spondylitis	0.00145	0.0817	CbGpPWpGaD
Vinorelbine—TUBB2A—Orphan transporters—ANO6—ankylosing spondylitis	0.0014	0.0791	CbGpPWpGaD
Vinorelbine—TUBB1—Orphan transporters—ANO6—ankylosing spondylitis	0.00137	0.0774	CbGpPWpGaD
Vinorelbine—TUBB4A—Orphan transporters—ANO6—ankylosing spondylitis	0.00123	0.0695	CbGpPWpGaD
Vinorelbine—TUBB4B—Orphan transporters—ANO6—ankylosing spondylitis	0.00113	0.0636	CbGpPWpGaD
Vinorelbine—TUBB8—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000817	0.0461	CbGpPWpGaD
Vinorelbine—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000685	0.00211	CcSEcCtD
Vinorelbine—Hypertension—Prednisolone—ankylosing spondylitis	0.00068	0.0021	CcSEcCtD
Vinorelbine—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000675	0.00208	CcSEcCtD
Vinorelbine—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000675	0.00208	CcSEcCtD
Vinorelbine—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000673	0.00208	CcSEcCtD
Vinorelbine—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000672	0.00207	CcSEcCtD
Vinorelbine—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000671	0.00207	CcSEcCtD
Vinorelbine—Alopecia—Dexamethasone—ankylosing spondylitis	0.000667	0.00206	CcSEcCtD
Vinorelbine—Alopecia—Betamethasone—ankylosing spondylitis	0.000667	0.00206	CcSEcCtD
Vinorelbine—Discomfort—Prednisolone—ankylosing spondylitis	0.000663	0.00204	CcSEcCtD
Vinorelbine—Angioedema—Triamcinolone—ankylosing spondylitis	0.000662	0.00204	CcSEcCtD
Vinorelbine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000661	0.00204	CcSEcCtD
Vinorelbine—Erythema—Dexamethasone—ankylosing spondylitis	0.000657	0.00203	CcSEcCtD
Vinorelbine—Erythema—Betamethasone—ankylosing spondylitis	0.000657	0.00203	CcSEcCtD
Vinorelbine—Malaise—Triamcinolone—ankylosing spondylitis	0.000653	0.00201	CcSEcCtD
Vinorelbine—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000652	0.00201	CcSEcCtD
Vinorelbine—Malaise—Methylprednisolone—ankylosing spondylitis	0.000652	0.00201	CcSEcCtD
Vinorelbine—Vertigo—Triamcinolone—ankylosing spondylitis	0.000651	0.00201	CcSEcCtD
Vinorelbine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00065	0.002	CcSEcCtD
Vinorelbine—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000646	0.00199	CcSEcCtD
Vinorelbine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000643	0.00198	CcSEcCtD
Vinorelbine—Neutropenia—Methotrexate—ankylosing spondylitis	0.000642	0.00198	CcSEcCtD
Vinorelbine—Cough—Triamcinolone—ankylosing spondylitis	0.000632	0.00195	CcSEcCtD
Vinorelbine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000628	0.00193	CcSEcCtD
Vinorelbine—Hypertension—Triamcinolone—ankylosing spondylitis	0.000626	0.00193	CcSEcCtD
Vinorelbine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000624	0.00192	CcSEcCtD
Vinorelbine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000617	0.0019	CcSEcCtD
Vinorelbine—Pneumonia—Methotrexate—ankylosing spondylitis	0.000616	0.0019	CcSEcCtD
Vinorelbine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000615	0.0019	CcSEcCtD
Vinorelbine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000615	0.0019	CcSEcCtD
Vinorelbine—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000612	0.00189	CcSEcCtD
Vinorelbine—Infestation—Methotrexate—ankylosing spondylitis	0.000612	0.00189	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000611	0.00188	CcSEcCtD
Vinorelbine—Flushing—Prednisone—ankylosing spondylitis	0.00061	0.00188	CcSEcCtD
Vinorelbine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00061	0.00188	CcSEcCtD
Vinorelbine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00061	0.00188	CcSEcCtD
Vinorelbine—Discomfort—Triamcinolone—ankylosing spondylitis	0.000609	0.00188	CcSEcCtD
Vinorelbine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000608	0.00187	CcSEcCtD
Vinorelbine—Angioedema—Dexamethasone—ankylosing spondylitis	0.000601	0.00185	CcSEcCtD
Vinorelbine—Angioedema—Betamethasone—ankylosing spondylitis	0.000601	0.00185	CcSEcCtD
Vinorelbine—Stomatitis—Methotrexate—ankylosing spondylitis	0.000597	0.00184	CcSEcCtD
Vinorelbine—Angiopathy—Prednisone—ankylosing spondylitis	0.000597	0.00184	CcSEcCtD
Vinorelbine—Immune system disorder—Prednisone—ankylosing spondylitis	0.000594	0.00183	CcSEcCtD
Vinorelbine—Malaise—Dexamethasone—ankylosing spondylitis	0.000593	0.00183	CcSEcCtD
Vinorelbine—Malaise—Betamethasone—ankylosing spondylitis	0.000593	0.00183	CcSEcCtD
Vinorelbine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000591	0.00182	CcSEcCtD
Vinorelbine—Vertigo—Dexamethasone—ankylosing spondylitis	0.000591	0.00182	CcSEcCtD
Vinorelbine—Vertigo—Betamethasone—ankylosing spondylitis	0.000591	0.00182	CcSEcCtD
Vinorelbine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00059	0.00182	CcSEcCtD
Vinorelbine—Arrhythmia—Prednisone—ankylosing spondylitis	0.000588	0.00181	CcSEcCtD
Vinorelbine—Infection—Triamcinolone—ankylosing spondylitis	0.000587	0.00181	CcSEcCtD
Vinorelbine—Infection—Methylprednisolone—ankylosing spondylitis	0.000586	0.00181	CcSEcCtD
Vinorelbine—Alopecia—Prednisone—ankylosing spondylitis	0.000581	0.00179	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000579	0.00179	CcSEcCtD
Vinorelbine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000579	0.00178	CcSEcCtD
Vinorelbine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000577	0.00178	CcSEcCtD
Vinorelbine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000577	0.00178	CcSEcCtD
Vinorelbine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000576	0.00178	CcSEcCtD
Vinorelbine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000573	0.00177	CcSEcCtD
Vinorelbine—Malnutrition—Prednisone—ankylosing spondylitis	0.000573	0.00177	CcSEcCtD
Vinorelbine—Erythema—Prednisone—ankylosing spondylitis	0.000573	0.00177	CcSEcCtD
Vinorelbine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000571	0.00176	CcSEcCtD
Vinorelbine—Hypertension—Betamethasone—ankylosing spondylitis	0.000568	0.00175	CcSEcCtD
Vinorelbine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000568	0.00175	CcSEcCtD
Vinorelbine—Myalgia—Betamethasone—ankylosing spondylitis	0.00056	0.00173	CcSEcCtD
Vinorelbine—Myalgia—Dexamethasone—ankylosing spondylitis	0.00056	0.00173	CcSEcCtD
Vinorelbine—Discomfort—Betamethasone—ankylosing spondylitis	0.000553	0.0017	CcSEcCtD
Vinorelbine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000553	0.0017	CcSEcCtD
Vinorelbine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000551	0.0017	CcSEcCtD
Vinorelbine—Pain—Prednisolone—ankylosing spondylitis	0.00055	0.0017	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000539	0.00166	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000538	0.00166	CcSEcCtD
Vinorelbine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000537	0.00165	CcSEcCtD
Vinorelbine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000537	0.00165	CcSEcCtD
Vinorelbine—Infection—Dexamethasone—ankylosing spondylitis	0.000533	0.00164	CcSEcCtD
Vinorelbine—Infection—Betamethasone—ankylosing spondylitis	0.000533	0.00164	CcSEcCtD
Vinorelbine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000531	0.00164	CcSEcCtD
Vinorelbine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000531	0.00164	CcSEcCtD
Vinorelbine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00053	0.00163	CcSEcCtD
Vinorelbine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00053	0.00163	CcSEcCtD
Vinorelbine—Anaemia—Prednisone—ankylosing spondylitis	0.000529	0.00163	CcSEcCtD
Vinorelbine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000527	0.00163	CcSEcCtD
Vinorelbine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000526	0.00162	CcSEcCtD
Vinorelbine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000526	0.00162	CcSEcCtD
Vinorelbine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000525	0.00162	CcSEcCtD
Vinorelbine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000525	0.00162	CcSEcCtD
Vinorelbine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000524	0.00161	CcSEcCtD
Vinorelbine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000524	0.00161	CcSEcCtD
Vinorelbine—Angioedema—Prednisone—ankylosing spondylitis	0.000523	0.00161	CcSEcCtD
Vinorelbine—Malaise—Prednisone—ankylosing spondylitis	0.000516	0.00159	CcSEcCtD
Vinorelbine—Vertigo—Prednisone—ankylosing spondylitis	0.000514	0.00159	CcSEcCtD
Vinorelbine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000511	0.00158	CcSEcCtD
Vinorelbine—Anorexia—Betamethasone—ankylosing spondylitis	0.000511	0.00158	CcSEcCtD
Vinorelbine—Urticaria—Prednisolone—ankylosing spondylitis	0.000511	0.00157	CcSEcCtD
Vinorelbine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00051	0.00157	CcSEcCtD
Vinorelbine—Fatigue—Triamcinolone—ankylosing spondylitis	0.00051	0.00157	CcSEcCtD
Vinorelbine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000509	0.00157	CcSEcCtD
Vinorelbine—Pain—Triamcinolone—ankylosing spondylitis	0.000506	0.00156	CcSEcCtD
Vinorelbine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000501	0.00155	CcSEcCtD
Vinorelbine—Hypotension—Betamethasone—ankylosing spondylitis	0.000501	0.00155	CcSEcCtD
Vinorelbine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000499	0.00154	CcSEcCtD
Vinorelbine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000496	0.00153	CcSEcCtD
Vinorelbine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000495	0.00153	CcSEcCtD
Vinorelbine—Hypertension—Prednisone—ankylosing spondylitis	0.000494	0.00152	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000489	0.00151	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000489	0.00151	CcSEcCtD
Vinorelbine—Myalgia—Prednisone—ankylosing spondylitis	0.000487	0.0015	CcSEcCtD
Vinorelbine—Arthralgia—Prednisone—ankylosing spondylitis	0.000487	0.0015	CcSEcCtD
Vinorelbine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000487	0.0015	CcSEcCtD
Vinorelbine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000486	0.0015	CcSEcCtD
Vinorelbine—Alopecia—Methotrexate—ankylosing spondylitis	0.000486	0.0015	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000484	0.00149	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000482	0.00149	CcSEcCtD
Vinorelbine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000482	0.00149	CcSEcCtD
Vinorelbine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000482	0.00149	CcSEcCtD
Vinorelbine—Discomfort—Prednisone—ankylosing spondylitis	0.000482	0.00148	CcSEcCtD
Vinorelbine—Erythema—Methotrexate—ankylosing spondylitis	0.000478	0.00148	CcSEcCtD
Vinorelbine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000478	0.00148	CcSEcCtD
Vinorelbine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000474	0.00146	CcSEcCtD
Vinorelbine—Urticaria—Triamcinolone—ankylosing spondylitis	0.00047	0.00145	CcSEcCtD
Vinorelbine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000469	0.00145	CcSEcCtD
Vinorelbine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000467	0.00144	CcSEcCtD
Vinorelbine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000467	0.00144	CcSEcCtD
Vinorelbine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000466	0.00144	CcSEcCtD
Vinorelbine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000466	0.00144	CcSEcCtD
Vinorelbine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000466	0.00144	CcSEcCtD
Vinorelbine—Infection—Prednisone—ankylosing spondylitis	0.000464	0.00143	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000463	0.00143	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000463	0.00143	CcSEcCtD
Vinorelbine—Back pain—Methotrexate—ankylosing spondylitis	0.000463	0.00143	CcSEcCtD
Vinorelbine—Fatigue—Betamethasone—ankylosing spondylitis	0.000463	0.00143	CcSEcCtD
Vinorelbine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000463	0.00143	CcSEcCtD
Vinorelbine—Pain—Dexamethasone—ankylosing spondylitis	0.000459	0.00141	CcSEcCtD
Vinorelbine—Pain—Betamethasone—ankylosing spondylitis	0.000459	0.00141	CcSEcCtD
Vinorelbine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000458	0.00141	CcSEcCtD
Vinorelbine—Tachycardia—Prednisone—ankylosing spondylitis	0.000456	0.00141	CcSEcCtD
Vinorelbine—Skin disorder—Prednisone—ankylosing spondylitis	0.000454	0.0014	CcSEcCtD
Vinorelbine—Anorexia—Prednisone—ankylosing spondylitis	0.000445	0.00137	CcSEcCtD
Vinorelbine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000444	0.00137	CcSEcCtD
Vinorelbine—Anaemia—Methotrexate—ankylosing spondylitis	0.000442	0.00136	CcSEcCtD
Vinorelbine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000442	0.00136	CcSEcCtD
Vinorelbine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000442	0.00136	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000439	0.00135	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000439	0.00135	CcSEcCtD
Vinorelbine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000436	0.00134	CcSEcCtD
Vinorelbine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000435	0.00134	CcSEcCtD
Vinorelbine—Malaise—Methotrexate—ankylosing spondylitis	0.000431	0.00133	CcSEcCtD
Vinorelbine—Vertigo—Methotrexate—ankylosing spondylitis	0.00043	0.00133	CcSEcCtD
Vinorelbine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000428	0.00132	CcSEcCtD
Vinorelbine—Urticaria—Betamethasone—ankylosing spondylitis	0.000426	0.00131	CcSEcCtD
Vinorelbine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000426	0.00131	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000426	0.00131	CcSEcCtD
Vinorelbine—Dizziness—Prednisolone—ankylosing spondylitis	0.000425	0.00131	CcSEcCtD
Vinorelbine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000424	0.00131	CcSEcCtD
Vinorelbine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000424	0.00131	CcSEcCtD
Vinorelbine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000424	0.00131	CcSEcCtD
Vinorelbine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000424	0.00131	CcSEcCtD
Vinorelbine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000424	0.00131	CcSEcCtD
Vinorelbine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000423	0.00131	CcSEcCtD
Vinorelbine—Paraesthesia—Prednisone—ankylosing spondylitis	0.00042	0.00129	CcSEcCtD
Vinorelbine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000418	0.00129	CcSEcCtD
Vinorelbine—Cough—Methotrexate—ankylosing spondylitis	0.000418	0.00129	CcSEcCtD
Vinorelbine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000417	0.00129	CcSEcCtD
Vinorelbine—TUBB2B—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000413	0.0233	CbGpPWpGaD
Vinorelbine—TUBB6—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000413	0.0233	CbGpPWpGaD
Vinorelbine—TUBB—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.00041	0.0231	CbGpPWpGaD
Vinorelbine—Chest pain—Methotrexate—ankylosing spondylitis	0.000407	0.00126	CcSEcCtD
Vinorelbine—Myalgia—Methotrexate—ankylosing spondylitis	0.000407	0.00126	CcSEcCtD
Vinorelbine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000407	0.00126	CcSEcCtD
Vinorelbine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000406	0.00125	CcSEcCtD
Vinorelbine—Rash—Prednisolone—ankylosing spondylitis	0.000405	0.00125	CcSEcCtD
Vinorelbine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000405	0.00125	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000405	0.00125	CcSEcCtD
Vinorelbine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000404	0.00124	CcSEcCtD
Vinorelbine—Fatigue—Prednisone—ankylosing spondylitis	0.000403	0.00124	CcSEcCtD
Vinorelbine—Headache—Prednisolone—ankylosing spondylitis	0.000403	0.00124	CcSEcCtD
Vinorelbine—Discomfort—Methotrexate—ankylosing spondylitis	0.000402	0.00124	CcSEcCtD
Vinorelbine—Constipation—Prednisone—ankylosing spondylitis	0.0004	0.00123	CcSEcCtD
Vinorelbine—TUBB3—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000399	0.0225	CbGpPWpGaD
Vinorelbine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000391	0.00121	CcSEcCtD
Vinorelbine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000391	0.0012	CcSEcCtD
Vinorelbine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00039	0.0012	CcSEcCtD
Vinorelbine—Infection—Methotrexate—ankylosing spondylitis	0.000388	0.0012	CcSEcCtD
Vinorelbine—TUBB2A—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000387	0.0218	CbGpPWpGaD
Vinorelbine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000385	0.00119	CcSEcCtD
Vinorelbine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000385	0.00119	CcSEcCtD
Vinorelbine—Asthenia—Betamethasone—ankylosing spondylitis	0.000385	0.00119	CcSEcCtD
Vinorelbine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000383	0.00118	CcSEcCtD
Vinorelbine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000382	0.00118	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000382	0.00118	CcSEcCtD
Vinorelbine—Nausea—Prednisolone—ankylosing spondylitis	0.000382	0.00118	CcSEcCtD
Vinorelbine—Pruritus—Betamethasone—ankylosing spondylitis	0.00038	0.00117	CcSEcCtD
Vinorelbine—Pruritus—Dexamethasone—ankylosing spondylitis	0.00038	0.00117	CcSEcCtD
Vinorelbine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000379	0.00117	CcSEcCtD
Vinorelbine—TUBB1—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000378	0.0213	CbGpPWpGaD
Vinorelbine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000376	0.00116	CcSEcCtD
Vinorelbine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000375	0.00116	CcSEcCtD
Vinorelbine—Rash—Triamcinolone—ankylosing spondylitis	0.000373	0.00115	CcSEcCtD
Vinorelbine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000373	0.00115	CcSEcCtD
Vinorelbine—Anorexia—Methotrexate—ankylosing spondylitis	0.000372	0.00115	CcSEcCtD
Vinorelbine—Rash—Methylprednisolone—ankylosing spondylitis	0.000372	0.00115	CcSEcCtD
Vinorelbine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000372	0.00115	CcSEcCtD
Vinorelbine—Urticaria—Prednisone—ankylosing spondylitis	0.000371	0.00114	CcSEcCtD
Vinorelbine—Headache—Triamcinolone—ankylosing spondylitis	0.00037	0.00114	CcSEcCtD
Vinorelbine—Headache—Methylprednisolone—ankylosing spondylitis	0.00037	0.00114	CcSEcCtD
Vinorelbine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000369	0.00114	CcSEcCtD
Vinorelbine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000369	0.00114	CcSEcCtD
Vinorelbine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000367	0.00113	CcSEcCtD
Vinorelbine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000367	0.00113	CcSEcCtD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000367	0.0207	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000367	0.0207	CbGpPWpGaD
Vinorelbine—Hypotension—Methotrexate—ankylosing spondylitis	0.000365	0.00113	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000356	0.0011	CcSEcCtD
Vinorelbine—Dizziness—Betamethasone—ankylosing spondylitis	0.000355	0.00109	CcSEcCtD
Vinorelbine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000355	0.00109	CcSEcCtD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000354	0.02	CbGpPWpGaD
Vinorelbine—Nausea—Triamcinolone—ankylosing spondylitis	0.000351	0.00108	CcSEcCtD
Vinorelbine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000351	0.00108	CcSEcCtD
Vinorelbine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00035	0.00108	CcSEcCtD
Vinorelbine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000348	0.00107	CcSEcCtD
Vinorelbine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000344	0.00106	CcSEcCtD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000343	0.0193	CbGpPWpGaD
Vinorelbine—Vomiting—Betamethasone—ankylosing spondylitis	0.000341	0.00105	CcSEcCtD
Vinorelbine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000341	0.00105	CcSEcCtD
Vinorelbine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000339	0.00105	CcSEcCtD
Vinorelbine—TUBB4A—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000339	0.0191	CbGpPWpGaD
Vinorelbine—Rash—Dexamethasone—ankylosing spondylitis	0.000338	0.00104	CcSEcCtD
Vinorelbine—Rash—Betamethasone—ankylosing spondylitis	0.000338	0.00104	CcSEcCtD
Vinorelbine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000338	0.00104	CcSEcCtD
Vinorelbine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000338	0.00104	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000337	0.00104	CcSEcCtD
Vinorelbine—Fatigue—Methotrexate—ankylosing spondylitis	0.000337	0.00104	CcSEcCtD
Vinorelbine—Headache—Betamethasone—ankylosing spondylitis	0.000336	0.00104	CcSEcCtD
Vinorelbine—Headache—Dexamethasone—ankylosing spondylitis	0.000336	0.00104	CcSEcCtD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000335	0.0189	CbGpPWpGaD
Vinorelbine—Asthenia—Prednisone—ankylosing spondylitis	0.000335	0.00103	CcSEcCtD
Vinorelbine—Pain—Methotrexate—ankylosing spondylitis	0.000334	0.00103	CcSEcCtD
Vinorelbine—Pruritus—Prednisone—ankylosing spondylitis	0.000331	0.00102	CcSEcCtD
Vinorelbine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000322	0.000992	CcSEcCtD
Vinorelbine—Diarrhoea—Prednisone—ankylosing spondylitis	0.00032	0.000986	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000319	0.000985	CcSEcCtD
Vinorelbine—Nausea—Dexamethasone—ankylosing spondylitis	0.000319	0.000983	CcSEcCtD
Vinorelbine—Nausea—Betamethasone—ankylosing spondylitis	0.000319	0.000983	CcSEcCtD
Vinorelbine—TUBB4B—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.00031	0.0175	CbGpPWpGaD
Vinorelbine—Urticaria—Methotrexate—ankylosing spondylitis	0.00031	0.000956	CcSEcCtD
Vinorelbine—Dizziness—Prednisone—ankylosing spondylitis	0.000309	0.000953	CcSEcCtD
Vinorelbine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000309	0.000952	CcSEcCtD
Vinorelbine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000309	0.000952	CcSEcCtD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000301	0.017	CbGpPWpGaD
Vinorelbine—Vomiting—Prednisone—ankylosing spondylitis	0.000297	0.000916	CcSEcCtD
Vinorelbine—Rash—Prednisone—ankylosing spondylitis	0.000295	0.000908	CcSEcCtD
Vinorelbine—Dermatitis—Prednisone—ankylosing spondylitis	0.000294	0.000908	CcSEcCtD
Vinorelbine—Headache—Prednisone—ankylosing spondylitis	0.000293	0.000903	CcSEcCtD
Vinorelbine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000288	0.000887	CcSEcCtD
Vinorelbine—Asthenia—Methotrexate—ankylosing spondylitis	0.00028	0.000864	CcSEcCtD
Vinorelbine—Nausea—Prednisone—ankylosing spondylitis	0.000278	0.000856	CcSEcCtD
Vinorelbine—Pruritus—Methotrexate—ankylosing spondylitis	0.000276	0.000852	CcSEcCtD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000275	0.0155	CbGpPWpGaD
Vinorelbine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000267	0.000824	CcSEcCtD
Vinorelbine—Dizziness—Methotrexate—ankylosing spondylitis	0.000258	0.000796	CcSEcCtD
Vinorelbine—Vomiting—Methotrexate—ankylosing spondylitis	0.000248	0.000766	CcSEcCtD
Vinorelbine—Rash—Methotrexate—ankylosing spondylitis	0.000246	0.000759	CcSEcCtD
Vinorelbine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000246	0.000758	CcSEcCtD
Vinorelbine—Headache—Methotrexate—ankylosing spondylitis	0.000245	0.000754	CcSEcCtD
Vinorelbine—Nausea—Methotrexate—ankylosing spondylitis	0.000232	0.000715	CcSEcCtD
Vinorelbine—TUBB2B—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000149	0.00839	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000149	0.00839	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000144	0.0081	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	0.000141	0.00794	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000139	0.00784	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000136	0.00767	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	0.000129	0.00726	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000122	0.00689	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	0.00012	0.00675	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000112	0.0063	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	8.81e-05	0.00496	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	8.76e-05	0.00494	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	8.76e-05	0.00494	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	8.37e-05	0.00472	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	8.33e-05	0.00469	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	7.72e-05	0.00435	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	3.33e-05	0.00188	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	1.75e-05	0.000986	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—B3GNT2—ankylosing spondylitis	1.65e-05	0.00093	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	1.65e-05	0.000927	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	1.08e-05	0.000608	CbGpPWpGaD
